Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
182.44
-3.15 (-1.70%)
Mar 3, 2025, 4:00 PM EST - Market closed
Inspire Medical Systems Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5,413 | 5,555 | 6,006 | 7,277 | 6,294 | 5,066 | |
| Market Cap Growth | -7.51% | -7.51% | -17.47% | 15.62% | 24.23% | 191.73% | |
| Enterprise Value | 4,999 | 5,170 | 5,567 | 6,859 | 6,115 | 4,856 | |
| Last Close Price | 182.44 | 185.38 | 203.43 | 251.88 | 230.06 | 188.09 | |
| PE Ratio | 104.25 | 103.82 | - | - | - | - | |
| Forward PE | 84.39 | 114.37 | - | - | - | - | |
| PS Ratio | 6.76 | 6.92 | 9.61 | 17.84 | 26.97 | 43.91 | |
| PB Ratio | 7.87 | 8.05 | 10.49 | 14.67 | 27.48 | 22.05 | |
| P/TBV Ratio | 8.05 | 8.05 | 10.49 | 14.67 | 27.48 | 22.05 | |
| P/FCF Ratio | 59.40 | 60.96 | 5865.34 | 2942.75 | - | - | |
| P/OCF Ratio | 41.56 | 42.65 | 243.63 | 629.04 | - | - | |
| EV/Sales Ratio | 6.23 | 6.44 | 8.91 | 16.82 | 26.20 | 42.09 | |
| EV/EBITDA Ratio | 117.26 | 121.26 | - | - | - | - | |
| EV/EBIT Ratio | 138.55 | 143.27 | - | - | - | - | |
| EV/FCF Ratio | 54.86 | 56.73 | 5436.59 | 2773.55 | - | - | |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.04 | 0.02 | 0.15 | 0.13 | |
| Debt / EBITDA Ratio | 0.66 | 0.66 | - | - | - | - | |
| Debt / FCF Ratio | 0.35 | 0.35 | 24.26 | 3.59 | - | - | |
| Asset Turnover | 1.08 | 1.08 | 1.01 | 0.95 | 0.81 | 0.50 | |
| Inventory Turnover | 2.16 | 2.16 | 4.22 | 4.54 | 2.59 | 2.46 | |
| Quick Ratio | 6.09 | 6.09 | 7.05 | 8.38 | 6.02 | 12.52 | |
| Current Ratio | 7.13 | 7.13 | 7.60 | 8.66 | 6.50 | 13.02 | |
| Return on Equity (ROE) | 8.48% | 8.48% | -3.96% | -12.38% | -18.33% | -30.96% | |
| Return on Assets (ROA) | 3.04% | 3.04% | -4.05% | -6.92% | -8.64% | -15.19% | |
| Return on Capital (ROIC) | 3.42% | 3.42% | -4.57% | -7.75% | -9.51% | -16.51% | |
| Return on Capital Employed (ROCE) | 5.01% | 5.01% | - | - | - | - | |
| Earnings Yield | 0.99% | 0.96% | -0.35% | -0.62% | -0.67% | -1.13% | |
| FCF Yield | 1.68% | 1.64% | 0.02% | 0.03% | -0.39% | -1.10% | |
| Buyback Yield / Dilution | -4.24% | -4.24% | -4.38% | -2.97% | -4.56% | -9.53% | |
| Total Shareholder Return | -4.24% | -4.24% | -4.38% | -2.97% | -4.56% | -9.53% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.